Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling
NCT ID: NCT01529047
Last Updated: 2023-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
361 participants
INTERVENTIONAL
2010-02-28
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indicated Prevention With At-Risk Gamblers
NCT00078273
Brief Therapies for Problem Gambling Substance Abusers
NCT00685048
Impact of Personalized Feedback Alone on Substance Use Behaviors
NCT01501318
Gambling and Brief Interventions
NCT00183599
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
NCT01159535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-person PFI
In-person personalized feedback intervention
Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
Web-based PFI
Web-based personalized feedback intervention
Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
Assessment Only
Complete online survey assessments only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet diagnostic criteria for one or more substance use disorder
17 Years
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Larimer
Professor, Psychiatry & Behavioral Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary E Larimer, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Washington Dept of Psychiatry & Behavioral Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35898
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.